Sodium

Chimerix to Present at B. Riley Virtual Oncology Conference

Retrieved on: 
Thursday, January 20, 2022 - 1:00pm

An audio webcast of the presentation will be available on the Investor Relations section of Chimerix's website at ir.chimerix.com, where it will be archived for approximately 90 days.

Key Points: 
  • An audio webcast of the presentation will be available on the Investor Relations section of Chimerix's website at ir.chimerix.com, where it will be archived for approximately 90 days.
  • Chimerix is a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases.
  • In June 2021, the U.S. Food and Drug Administration granted approval of TEMBEXA for the treatment of smallpox as a medical countermeasure.
  • The Company has two other advanced clinical-stage development programs, ONC201 and dociparstat sodium (DSTAT).

Nabati Plant Eggz™ and Nabati Cheeze Now Available at The Grocery Outlet in California

Retrieved on: 
Wednesday, January 19, 2022 - 2:00pm

The Grocery Outlet has supplied customers, retailers, and distributors for over 20 years with a wide range of high quality, competitively priced products.

Key Points: 
  • The Grocery Outlet has supplied customers, retailers, and distributors for over 20 years with a wide range of high quality, competitively priced products.
  • We are thrilled to be partnering with The Grocery Outlet to expand access for our customer base in the California market, said Nabati Foods Interim CEO, Michael Aucoin.
  • Nabati Plant Eggz is the only plant-based liquid egg alternative made by a Canadian company, and the only plant-based liquid egg alternative that is free of both soy and gluten.
  • Each serving of Nabati Plant Eggz has just 100 calories, with six grams of protein, two grams of fibre, and no cholesterol.

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research

Retrieved on: 
Tuesday, January 18, 2022 - 9:01pm

ONC201 is an orally administered small molecule dopamine receptor D2 (DRD2) antagonist and caseinolytic protease (ClpP) agonist.

Key Points: 
  • ONC201 is an orally administered small molecule dopamine receptor D2 (DRD2) antagonist and caseinolytic protease (ClpP) agonist.
  • We look forward to continuing to explore additional tumors where ONC201 may provide therapeutic benefit to existing standards of care.
  • This open-label Phase 2 investigator-initiated study treated 30 patients with rare neuroendocrine tumors.
  • A third cohort included patients with other neuroendocrine tumors, including desmoplastic small round cell tumor (DSRCT), dosed weekly with ONC201.

Praxis Precision Medicines Announces Publication of Preclinical Data Highlighting Differentiated and Potent Antiepileptic Activity of PRAX-562

Retrieved on: 
Tuesday, January 18, 2022 - 2:00pm

BOSTON, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the publication of data in the journal Epilepsia from a preclinical study of PRAX-562, a preferential persistent sodium channel blocker currently in development for the potential treatment of rare adult cephalgias and Developmental and Epileptic Encephalopathies (DEEs).

Key Points: 
  • This preclinical study investigated the effects of PRAX-562 on intrinsic neuronal excitability and protection from induced seizures as compared to sodium channel blockers used as standard-of-care antiepileptic treatments.
  • In the study, PRAX-562 demonstrated robust preclinical antiseizure activity and significantly improved preclinical tolerability, with improved or comparable efficacy when evaluated against currently used sodium channel blockers.
  • This study supports the potential for PRAX-562, a persistent sodium channel blocker with a favorable therapeutic window, to improve tolerability relative to marketed therapies while achieving potent antiseizure activity.
  • Praxis undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

Juna Announces Its Much-Anticipated Detox Drops January 2022

Retrieved on: 
Friday, January 14, 2022 - 6:58pm

The beauty of Detox Drops, like all products from Juna, lies in its superlative quality natural ingredients, which are science-backed and completely safe.

Key Points: 
  • The beauty of Detox Drops, like all products from Juna, lies in its superlative quality natural ingredients, which are science-backed and completely safe.
  • The active ingredients in Detox Drops include chlorophyllin from white mulberry, sodium, copper, organic flax/coconut-derived glycerin, mint essential oil, lemon essential oil, citric acid, distilled purified water, and other organic extracts.
  • Juna is launching its Detox Drops at an attractive inaugural price.
  • As the research-backed key ingredient in Detox Drops, chlorophyll is the superhero agent that amplifies the body's oxygen supply for cellular regeneration, boosts metabolism, stimulates the organs, clears impurities, and clarifies the mind and body, shared the founders.

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference

Retrieved on: 
Friday, January 14, 2022 - 2:05pm

DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (Nasdaq: NOVN), today announced that data from the Companys completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel (previously referred to as SB206) for molluscum contagiosum will be presented at the 2022 Winter Clinical Dermatology Conference, being held January 14-19, 2022, in Koloa, Hawaii.

Key Points: 
  • DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (Nasdaq: NOVN), today announced that data from the Companys completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel (previously referred to as SB206) for molluscum contagiosum will be presented at the 2022 Winter Clinical Dermatology Conference, being held January 14-19, 2022, in Koloa, Hawaii.
  • There is currently no US Food & Drug Administration (FDA) approved medication indicated for the treatment of molluscum.
  • The latter represents a clinical sign of inflammation and imminent resolution of molluscum lesions that has never been prospectively studied in a molluscum clinical trial.
  • For more information about the conference, visit: https://fallclinical.health/
    Novan, Inc. is a pre-commercial nitric oxide-based pharmaceutical company focused on dermatology and anti-infective therapies.

Obstacle Course Racing Superstar, Hunter McIntyre and World's Toughest Mudder Champion, Katie Knight Sign with BOA Nutrition

Retrieved on: 
Friday, January 14, 2022 - 1:00pm

RALEIGH, N.C., Jan. 14, 2022 /PRNewswire/ -- BOA Nutrition announced it has inked a deal with the 7-time champion and world-record-holder in multiple obstacle course racing disciplines.

Key Points: 
  • RALEIGH, N.C., Jan. 14, 2022 /PRNewswire/ -- BOA Nutrition announced it has inked a deal with the 7-time champion and world-record-holder in multiple obstacle course racing disciplines.
  • Hunter McIntyre holds titles from Hyrox , Tough Mudder X , OCR , the Murph Challenge , and Broken Skull Ranch .
  • The company announced it has also signed Katie Knight , the 2021 World's Toughest Mudder Champion , who recently decided to pursue obstacle course racing on a more serious basis.
  • "We are delighted that Hunter and Katie chose to become an ambassador for the company," stated Jon Pritchett, BOA Nutrition President & CEO.

Re-2Ox Process Extracts 99 Percent of Rubidium from Granada Gold Mine's Battery Metals Zone

Retrieved on: 
Tuesday, January 11, 2022 - 12:30pm

Stage I bench-scale testing has been completed at SGS Lakefield using the Re-2Ox process for the recovery of performance-enhancing battery metal Rubidium from Granada Gold Mine's drill core. Test work was funded and supervised by Canada Silver Cobalt Works

Key Points: 
  • "The company plans to reintegrate the precious metal leaching stage into the Re-2Ox process thereby making the process more viable.
  • Canada Silver Cobalt aims to supply high-value metals to the electric vehicle (EV) battery market using the Re-2Ox process.
  • The recent discovery of a potentially large, low-grade alkali and rare earth mineralized zone at Granada Gold Mine meets the Company criteria.
  • Drill core from the EV battery metals discovery zone, from the northern part of the Big Claim at Granada Gold Mine, was used for the test work at SGS Canada.

US Consumers' Dietary Goals Are at Odds with Recommendations from Health Authorities

Retrieved on: 
Monday, January 10, 2022 - 8:00am

Consumers' dietary goals are often at odds with recommendations from health authorities.

Key Points: 
  • Consumers' dietary goals are often at odds with recommendations from health authorities.
  • An example is that government-recommended dietary guidelines suggest that consumers need more fiber and less sodium in their daily diets.
  • Yet, consumers focus on eating more protein, not fiber, and consume more sodium than is recommended, according to NPD's recently released America's Health Pulse: Closing the Gap Between Wants and Needs .
  • "Food manufacturers and retailers can better position their products by understanding their consumers' nutritional gaps and goals for living healthier lives.

IV Therapy in Pasadena Now Offered by Muscle Lab

Retrieved on: 
Friday, January 7, 2022 - 12:32pm

Muscle Lab recently started to offer vitamin IV Therapy in their Pasadena location .

Key Points: 
  • Muscle Lab recently started to offer vitamin IV Therapy in their Pasadena location .
  • Los Angeles residents are eager to get an IV drip, and Muscle Lab has seen an increasing number of individuals wanting to try IV Therapy for their first time.
  • But now, IV Therapy is available to the general public to reap the benefits, the most popular being the hangover IV drip .
  • Muscle Lab's Pasadena location offers a wide range of vitamin IV Drips to choose from, depending on symptoms and goals.